Epidemiology of meningitis in Al-Ain, United Arab Emirates, 2000-2005. by Dash, Nihar et al.
Dash, N; Ameen, AS; Sheek-Hussein, MM (2006) Epidemiology of
meningitis in Al-Ain, United Arab Emirates, 2000-2005. Int J Infect
Dis, 11 (4). pp. 309-12. ISSN 1201-9712 DOI: https://doi.org/10.1016/j.ijid.2006.05.009
Downloaded from: http://researchonline.lshtm.ac.uk/20508/
DOI: 10.1016/j.ijid.2006.05.009
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/3.0/
Epidemiology of meningitis in Al-Ain, United Arab
Emirates, 2000—2005§
Nihar Dash a,d,*, Abdulmajeed S. Ameen b, Mohamud M. Sheek-Hussein c,
Raymond A. Smego Jrd
aDepartment of Control of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK
bUnited Arab Emirates University, Al-Ain, United Arab Emirates
cDepartment of Preventive Medicine, Ministry of Health, Al-Ain, United Arab Emirates
dOman Medical College, Sohar Campus, Sultanate of Oman
Received 27 February 2006; received in revised form 1 May 2006; accepted 31 May 2006
Corresponding Editor: Andy I.M. Hoepelman, Utrecht, The Netherlands
International Journal of Infectious Diseases (2007) 11, 309—312
http://intl.elsevierhealth.com/journals/ijid
KEYWORDS
Meningitis;
Epidemiology;
Bacterial;
Diagnosis;
Middle East
Summary
Objective: To describe the epidemiologic features of meningitis in Al-Ain Medical District, United
Arab Emirates from January 2000 through June 2005.
Methods: A retrospective review of clinical records and notification forms for cases of meningitis
reported to the Department of Preventive Medicine, Al-Ain. Data collected and compiled included
demographic features, causative microbiologic agents, and annual incidence rates of meningitis,
by etiology.
Results: Ninety-two cases of meningitis were reported during the study period; 53% were
bacterial and 37% were viral in origin. Neisseria meningitidis was the leading bacterial pathogen
(35%) followed by Streptococcus pneumoniae (16%). Ten percent of clinically diagnosed cases of
meningitis had no causative microorganism recovered, and in 33% of patients with presumed
pyogenic meningitis no specific bacterial pathogen could be identified. The peak occurrence of
meningitis was in young children less than one year old. Most cases of meningococcal meningitis
were seen among prison inmates and laborers, while viral meningitis occurred mainly in children
and young adults attending school. The incidence rate of meningitis in Al-Ain ranged between
2.2/100 000 population in 2000 and 1/100 000 in 2005, with an overall downward trend by year.
The incidence of Haemophilus influenzae type b decreased significantly after implementation of
the national immunization program in 1999.
Conclusions: Improvedmethods of bacterial detection including isolate serotyping must bemade
available in order to further reduce mortality and morbidity from meningitis.
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Introduction
Meningitis is a common disease worldwide and remains a
major international health problem. In 2002, meningitis
caused an estimated 173 000 deaths worldwide, mostly
among children from the developing world.1 The occurrence
and microbial etiology of meningitis varies according to
geographic region, with degrees of endemicity. During the
pre-meningitis vaccination era, the incidence of meningitis in
the United Arab Emirates (UAE) was similar to other countries
and Haemophilus influenzae type b (Hib) was the most
common cause.2 Since the introduction of the conjugate
Hib vaccine in UAE’s national immunization program in
1999, the absolute number of cases ofmeningitis attributable
to Hib has declined, but its impact on the epidemiology of
meningitis due to other causes has received little attention.
The present study describes recent epidemiologic features of
meningitis in Al-Ain Medical District of UAE.
Patients and methods
The city of Al-Ain is located in the emirate of Abu Dhabi, and
its population has grown from a few thousand in the pre-oil
boom days to around 410 000 in 2005.3 Al-Ain possesses high
quality medical facilities including primary health centers,
private clinics, and hospitals. In Al-Ain Medical District,
meningitis is a reportable disease, and mandatory notifica-
tion of each case to the Department of Preventive Medicine
within the Ministry of Health is required within 24 hours.
Physicians in the district are provided with official case
definitions of meningitis and case reporting guidelines.
All clinical records (case notification forms and hospital
medical records) for cases of meningitis reported to the
DepartmentofPreventiveMedicine fromJanuary2000 through
June 2005 were examined for basic patient demographic
information including age, gender, nationality, microbiologic
etiology of meningitis, travel history, vaccination status
against meningitis causes, underlying conditions, and clinical
outcome. The following case definitions were used in this
study: (1) a diagnosis of meningitis was based upon clinical
assessment, with features including fever, headache, vomit-
ing, neck stiffness, convulsions, and altered consciousness; (2)
bacterial meningitis was confirmed by a positive Gram stain of
cerebrospinal fluid (CSF), by cultural isolation of a relevant
microorganism from CSF and/or blood, or by detection of
bacterial antigens in CSF; (3) viral meningitis was diagnosed
presumptively on clinical grounds and by exclusion of bacterial
meningitis.
Results
During the study period, 92 cases of meningitis were reported
in the medical district of Al-Ain, of which 53% were bacterial
and 37% were viral in origin. Nine cases (10%) were clinically
diagnosed as meningitis but in each of these instances no
specific microbial etiology could be determined. Among
bacterial causes of meningitis, Neisseria meningitidis was
the most frequent causative agent, occurring in 17 (35%)
cases (mostly adults), followed by Streptococcus pneumoniae
in eight (16%) cases. All four cases (8%) of meningitis due to
Mycobacterium tuberculosis were seen in adults, with a
mean age of 30 years. The BCG vaccination status was not
available for these cases, and none of these subjects was an
immunocompromised host. One case (2%) each of Escherichia
coli and group B streptococcal meningitis, respectively,
occurred in neonates. Both cases (4%) of meningitis due to
H. influenzae occurred in children who had not been pre-
viously vaccinated. Sixteen (33%) cases of meningitis were
presumptively attributed to bacterial pathogens without
final determination of causative organisms (Figures 1 and 2).
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Figure 1 Causative agents of bacterial meningitis.
Figure 2 Causative agents of bacterial meningitis in different age groups.
Most cases of meningococcal meningitis occurred in prison
inmates and laborers. Twelve bacteriologically-confirmed
cases of meningitis due to N. meningitidis were reported
among inmates of Al-Ain prison between December 2000 and
April 2001. All affected subjects were adult males (mean age
30 years) who received appropriate treatment and fully
recovered. Cases of viral meningitis were mainly seen in
children, teenagers, and young adults attending school.
The incidence of meningitis due to Hib began to decrease
significantly after implementation of the national immuniza-
tion program in 1999, and this trend continued during the
study period. The incidence of meningeal infection of all
types in Al-Ain Medical District ranged from 2.2/100 000
population in 2000 to 1/100 000 population in 2005, with
an overall downward trend by year (Figure 3).
The age group between 0 and 5 years had the highest rate
of meningitis, with the largest number of cases occurring in
children less than one year old. Overall, themean patient age
was 19 years (SD = 1.660). An increase in the incidence of
meningitis in the 21—30 year age group was attributed to the
outbreak of meningococcal infection that occurred among
inmates of Al-Ain Prison in 2001. There was no variance in
incidence by gender, with both sexes being equally affected.
Meningitis cases were observed throughout the year without
any seasonal variation.
Fever, neck stiffness, seizure, vomiting, and bulging fon-
tanelle were the most frequent presenting features. The
meningitis case-fatality rate was 11% (10 of 92). Mortality
according to microorganism was as follows: bacterial (docu-
mented or presumptive) 16% (8 of 49); viral 3% (1 of 34);
unknown etiology 11% (1 of 9).
Discussion
Except for a prison-related meningitis outbreak in 2001,
there has been a decline in the incidence of meningitis cases
in Al-Ain over the past five years. This decrease can poten-
tially be attributed to multiple factors including improve-
ments in living conditions, regional introduction of vaccines
against H. influenzae type b and N. meningitidis, better
availability of healthcare facilities, earlier detection of
meningitis, and improved prevention and control strategies
by the Ministry of Health against all types of meningitis. The
decline in incidence rates is unlikely to have been affected by
changes in surveillance because no modifications were made
in the national diagnostic criteria used for meningitis, and
only passive surveillance was conducted throughout the
entire study period.
H. influenzae type b, once the leading cause of meningitis
in children under 5 years of age, has become rare since the
introduction of conjugate Hib vaccination in UAE in 1999.2
Similar epidemiology has been reported from the USA and
Europe, and from the neighboring countries of Qatar and
Saudi Arabia where the incidence of all forms of invasive Hib
disease has been dramatically reduced as a result of systema-
tic and mandatory immunization of all children.4—8 Only two
isolates of H. influenzae were recovered from CSF during our
study period, both during 2000 when the Hib vaccination had
only recently been introduced into the community. Since
2000, there have been no cases of Hib meningitis reported,
thus demonstrating the remarkable success of the national
immunization program in UAE.
None of the isolated bacterial agents were further typed
or serogrouped in order to precisely identify the circulating
strain. Sub-classification (serotyping) is especially important
for N. meningitidis, in which immunity is group-specific, and
information about the predominant strain is very important
in developing and implementing an effective community-
based vaccine strategy.4 Similarly, in spite of a very well-
constructed reporting form available from the Ministry of
Health, routine antibiotic sensitivity test results were lacking
in most cases. This observation is extremely relevant, since
resistance of pneumococci to penicillin and cephalosporins
has been increasing globally in the past decade.9 In many
parts of the world, penicillin can no longer be used by itself to
empirically treat suspected bacterial meningitis.10,11
Furthermore, H. influenzae isolates can produce b-lacta-
mases, and have widely developed resistance to antibiotics
such as ampicillin and chloramphenicol.12 Antibiotic sensi-
tivity testing plays a crucial role in formulating effective
treatment, reducing unnecessary use of broad-spectrum
agents, and limiting spread of drug-resistant strains. We
suggest that all bacterial isolates recovered from CSF must
be tested for antimicrobial susceptibility using Kirby—Bauer
disk diffusion, E-test, and/or b-lactamase detection meth-
ods.13
In this study, the occurrence of nine (10%) cases of
meningitis of undetermined etiology, as well as the failure
to isolate a causative microorganism from 19 (33%) cases of
presumed bacterial meningitis, reflects the need for
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Figure 3 Distribution of meningitis cases by year.
improvement of laboratory procedures and practices in UAE.
Etiologic diagnosis of meningitis can be enhanced by using
antigen detection (e.g., latex agglutination) and nucleic acid
amplification (e.g., polymerase chain reaction) techni-
ques.14,15 Antigen testing can be very useful when a patient
is partially treated with antibiotics (often self-administered)
before examination of CSF, leading to a false-negative Gram
stain and/or culture. In fact, failure to isolate a causative
agent is most often related to antibiotic treatment received
prior to lumbar puncture. The above-mentioned diagnostic
methods should be routinely incorporated into standard
laboratory practice and made available at all the reference
laboratories.
Acute bacterial meningitis in childhood has considerable
mortality, complications, and long-term neurologic seque-
lae.16,17 A limitation of our retrospective study was an
inability to fully determine the morbidity of meningitis such
as hydrocephalus, cerebral edema, sensorineural hearing
loss, vision impairment, and failure to thrive that are likely
to occur in UAE because patient-specific clinical outcomes
were generally unavailable. Long-term clinical follow-up and
information about outcome of meningitis, especially for
cases involving young children, are needed and should be
recorded regularly and accurately.
In conclusion, correct and early identification of the pre-
cise etiologic agent and timely institution of appropriate
antimicrobial therapy is of paramount importance in the
successful management of meningitis. There is an urgent
need to upgrade the diagnostic and reporting system for
meningitis in UAE. Improved methods of bacterial detection
and isolate serotyping must bemade available in UAE in order
to further reduce mortality and morbidity from meningitis.
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